Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Interventional Neurology Market Size study, by Product (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices) By Disease Pathology (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation and Fistulas, Other Disease Pathologies) and regional forecasts 2019-2026.

  • BIZ3446121
  • 200 Pages
  • January 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Interventional Neurology Market is valued approximately at USD 2.1 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2019-2026. Interventional neurology is the novel procedure adopted for the non-surgical treatment in neurological diseases. Interventional neurology has wide range of application in the diagnosis of peripheral systems and nervous system. Large target patient population, ongoing product development and commercialization and favorable medical reimbursements are key driving forces of market growth. As per the World Health Organization, Neurological disorder accounts for 6.3% of the global diseases burden. According to the European Academy of Neurology, in 2018, about 220.7 million people in Europe suffer from neurological diseases. In addition, expansion of healthcare infrastructure across emerging markets coupled with growing demand for effective neurovascular devices are further contributing towards the market growth. Moreover, increasing research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures is expected to create significant growth opportunity in the market over the forecast period. According to the Indian Brand Equity Foundation, in 2018, with the rising cases of neurological disorder government spend about USD 1.14 billion for the treatment and providing awareness of CNS disorders. Also, In United States the total spending on mental health treatment accounts for 2.4% of total government health spending along with the median allocation of fund in the psychiatric hospital by government is 80% of total government health spending. However, Stringent regulations and lack of skilled Neurosurgeons impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global interventional Neurology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population, high purchasing power coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising geriatric population, growing disposable income, rising incidences of neurological diseases and improving healthcare infrastructure would create lucrative growth prospects for the Interventional Neurology market across Asia-Pacific region.

Major market player included in this report are:

Stryker Corporation

Medtronic PLC

Johnson & Johnson

Terumo Corporation

Penumbra, Inc.

Boston Scientific Corporation

Microport Scientific Corporation

Merit Medical Systems, Inc.

W.L. Gore & Associates, Inc.

Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Aneurysm Coiling & Embolization Devices

Cerebral Balloon Angioplasty and Stenting Systems

Support Devices

Neurothrombectomy Devices

By Disease Pathology:

Ischemic Strokes

Cerebral Aneurysms

Arteriovenous Malformation and Fistulas

Other Disease Pathologies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Interventional Neurology Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)

1.2.1. Interventional Neurology Market, by Region, 2017-2026 (USD Billion)

1.2.2. Interventional Neurology Market, by Product, 2017-2026 (USD Billion)

1.2.3. Interventional Neurology Market, by Disease Pathology, 2017-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Interventional Neurology Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Interventional Neurology Market Dynamics

3.1. Interventional Neurology Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Interventional Neurology Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Interventional Neurology Market, by Product

5.1. Market Snapshot

5.2. Global Interventional Neurology Market by Product, Performance - Potential Analysis

5.3. Global Interventional Neurology Market Estimates & Forecasts by Product 2016-2026 (USD Billion)

5.4. Interventional Neurology Market, Sub Segment Analysis

5.4.1. Aneurysm Coiling & Embolization Devices

5.4.2. Cerebral Balloon Angioplasty and Stenting Systems

5.4.3. Support Devices

5.4.4. Neurothrombectomy Devices

Chapter 6. Global Interventional Neurology Market, by Disease Pathology

6.1. Market Snapshot

6.2. Global Interventional Neurology Market by Disease Pathology, Performance - Potential Analysis

6.3. Global Interventional Neurology Market Estimates & Forecasts by Disease Pathology 2016-2026 (USD Billion)

6.4. Interventional Neurology Market, Sub Segment Analysis

6.4.1. Ischemic Strokes

6.4.2. Cerebral Aneurysms

6.4.3. Arteriovenous Malformation and Fistulas

6.4.4. Other Disease Pathologies

Chapter 7. Global Interventional Neurology Market, Regional Analysis

7.1. Interventional Neurology Market, Regional Market Snapshot

7.2. North America Interventional Neurology Market

7.2.1. U.S. Interventional Neurology Market

7.2.1.1. Product breakdown estimates & forecasts, 2016-2026

7.2.1.2. Disease Pathology breakdown estimates & forecasts, 2016-2026

7.2.2. Canada Interventional Neurology Market

7.3. Europe Interventional Neurology Market Snapshot

7.3.1. U.K. Interventional Neurology Market

7.3.2. Rest of Europe Interventional Neurology Market

7.4. Asia-Pacific Interventional Neurology Market Snapshot

7.4.1. China Interventional Neurology Market

7.4.2. India Interventional Neurology Market

7.4.3. Japan Interventional Neurology Market

7.4.4. Rest of Asia Pacific Interventional Neurology Market

7.5. Latin America Interventional Neurology Market Snapshot

7.5.1. Brazil Interventional Neurology Market

7.5.2. Mexico Interventional Neurology Market

7.6. Rest of The World Interventional Neurology Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Stryker Corporation

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Medtronic PLC

8.2.3. Johnson & Johnson

8.2.4. Terumo Corporation

8.2.5. Penumbra, Inc.

8.2.6. Boston Scientific Corporation

8.2.7. Microport Scientific Corporation

8.2.8. Merit Medical Systems, Inc.

8.2.9. W.L. Gore & Associates, Inc.

8.2.10. Abbott Laboratories

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL INTERVENTIONAL NEUROLOGY MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL INTERVENTIONAL NEUROLOGY MARKET

TABLE 3. GLOBAL INTERVENTIONAL NEUROLOGY MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)

TABLE 8. GLOBAL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY DISEASE PATHOLOGY 2016-2026 (USD BILLION)

TABLE 9. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 10. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. U.S. INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. U.S. INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 21. U.S. INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 22. CANADA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 23. CANADA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 24. CANADA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 25. UK INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 26. UK INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 27. UK INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. GERMANY INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 29. GERMANY INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 30. GERMANY INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. ROE INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 32. ROE INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 33. ROE INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. CHINA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 35. CHINA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 36. CHINA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. INDIA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 38. INDIA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 39. INDIA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. JAPAN INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 41. JAPAN INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 42. JAPAN INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. ROAPAC INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 44. ROAPAC INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. ROAPAC INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. BRAZIL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 47. BRAZIL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. BRAZIL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. MEXICO INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 50. MEXICO INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 51. MEXICO INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. ROLA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 53. ROLA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 54. ROLA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. ROW INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 56. ROW INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. ROW INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2026 © Copyright Big Market Research